Improve hand dexterity with imagery
- Trial ID
- NCT07193303
- Official Title
- The Immediate Effect of Mental Imagery on Upper Extremity Skills With the Patients of Parkinson's Disease
- Goal
- Improve hand dexterity with imagery
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Kahramanmaras Sutcu Imam University
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- PARKINSON DISEASE (Disorder), Mental Imagery, Motor Imagery
- Interventions
- mental imagination
Summary For Families
The goal is to find out whether guided mental imagery can produce immediate improvements in hand and arm skills that people with Parkinson's use for everyday tasks. The approach asks participants to mentally rehearse specific upper‑limb movements, which activates motor planning networks in the brain and can prime better movement execution without physical practice, and it is noninvasive so it can be used alongside usual medications like levodopa. Effects are measured right after the mental imagery on standard dexterity and motor tasks to see if there is a quick benefit. The trial is looking for people aged 40 to 75 with idiopathic Parkinson's, Hoehn and Yahr stage 4 or lower, adequate cognition (MMSE ≥24 for those receiving training, ≥18 for those not), no other neurologic or systemic disease, and no upper extremity contractures; people on neuroleptics or antidepressants, with treated psychiatric illness, or with orthopedic/other neurologic problems affecting the hands are excluded.
Locations
- Kahramanmaraş Sütçü imam University, Kahramanmaraş, Onikişubat, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying mental imagination. The goal is to find out whether guided mental imagery can produce immediate improvements in hand and arm skills that people with Parkinson's use for everyday tasks. The approach asks participants to mentally rehearse specific upper‑limb movements, which activates motor planning networks in the brain and can prime better movement execution without physical practice, and it is noninvasive so it can be used alongside usual medications like levodopa. Effects are measured right after the mental imagery on standard dexterity and motor tasks to see if there is a quick benefit. The trial is looking for people aged 40 to 75 with idiopathic Parkinson's, Hoehn and Yahr stage 4 or lower, adequate cognition (MMSE ≥24 for those receiving training, ≥18 for those not), no other neurologic or systemic disease, and no upper extremity contractures; people on neuroleptics or antidepressants, with treated psychiatric illness, or with orthopedic/other neurologic problems affecting the hands are excluded.
- Who can participate?
- Participants must be between 40 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.